Page 1 of Clinical Trials for ( Carcinoma AND Endometrioid ), 70 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Not yet recruiting
PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion
Last Updated: September 12, 2005
Condition(s): Ovarian Cancer
2
Recruiting
Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)
Last Updated: November 29, 2011
Condition(s): Hyperplasia; Endometrial Cancer
3
Recruiting
Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
Last Updated: April 2, 2011
Condition(s): Cervical Cancer; Endometrial Cancer
4
Completed
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
Last Updated: September 16, 2010
Condition(s): Endometrial Cancer
5
Active, not recruiting
Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer
Last Updated: November 15, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mixed Epithelial Carcinoma; Ovarian Mucinous Cystadenocarcinoma; Ovarian Serous Cystadenocarcinoma; Ovarian Undifferentiated Adenocarcinoma; Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer; Stage III Ovarian Epithelial Cancer; Stage IV Ovarian Epithelial Cancer
6
Terminated
A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers
Last Updated: April 22, 2012
Condition(s): Uterine Cancer
7
Active, not recruiting
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer
Last Updated: March 29, 2011
Condition(s): Surgically Staged Endometrial Cancer; Stage IIB Uterine Corpus Cancer; Stage I-IIb Papillary Serous; Stage I-IIb Clear Cell Endometrial Cancer
8
Completed
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
Last Updated: March 28, 2012
Condition(s): Brenner Tumor; Fallopian Tube Cancer; Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mixed Epithelial Carcinoma; Ovarian Mucinous Cystadenocarcinoma; Ovarian Serous Cystadenocarcinoma; Ovarian Undifferentiated Adenocarcinoma; Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer; Stage III Ovarian Epithelial Cancer; Stage IV Ovarian Epithelial Cancer
9
Completed
Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
Last Updated: May 10, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
10
Recruiting
Beta-Blocker / Ovarian
Last Updated: March 13, 2012
Condition(s): Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Cancer
11
Recruiting
Temsirolimus and Bevacizumab in Treating Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial Cancer, Liver Cancer, Islet Cell Cancer, or Carcinoid Tumor
Last Updated: May 2, 2012
Condition(s): Endometrial Cancer; Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Liver Cancer; Lung Cancer; Ovarian Cancer
12
Completed
Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
Last Updated: April 23, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
13
Completed
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
Last Updated: April 23, 2011
Condition(s): Ovarian Cancer; Primary Peritoneal Cavity Cancer
14
Completed
Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer
Last Updated: February 25, 2012
Condition(s): Ovarian Cancer; Primary Peritoneal Cavity Cancer
15
Recruiting
IGFBP-3 in Ovarian Cancer Invasion
Last Updated: September 9, 2005
Condition(s): Ovarian Carcinoma
16
Not yet recruiting
Prognostic Biomarkers in Patients With Endometrial Cancer
Last Updated: September 23, 2010
Condition(s): Endometrial Cancer
17
Completed
P16 Staining as Prognostic Biomarker in Serous Papillary Endometrial Cancer
Last Updated: December 26, 2010
Condition(s): Serous Papillary Endometrial Cancer
18
Completed
Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer
Last Updated: April 23, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
19
Completed
Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
Last Updated: April 23, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
20
Completed
Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
Last Updated: April 23, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Carcinoma%2C+Endometrioid

Page 1 of Clinical Trials for ( Carcinoma AND Endometrioid ), 70 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About